Heidi Øyen Flemmen

  • Consultant of neurology; MD

Heidi Øyen Flemmen has a medical degree from University of Bergen (2000) and is a specialist in neurology from 2014. She works as a senior consultant at the Department of Neurology, Telemark Hosptial, with a special interest in MS patients.

As of August 2016 she has been working 50 % as a PhD student within this project and 50 % as a clinician at Department of Neurology in Telemark Hospital.  

Project title: "Socioeconomic factors as predictors for disease susceptibility and disease progression in Multiple sclerosis."

Research project: Heidi Øyen Flemmen is doing her PhD project on multiple sclerosis and socioeconomic factors. The project title is socioeconomic factors as predictors for disease susceptibility and disease progression in Multiple sclerosis. The aim of this study is to evaluate factors predicting disease susceptibility, progression and access to treatment in a complete geographically well-defined cohort of all MS patients in Oslo, Buskerud and Telemark

Main supervisor: Elisabeth Gulowsen Celius (MD, PhD.)
Co-supervisors: Pål Berg-Hansen (MD, PhD) and Kristian Heldal (MD, PhD, senior consultant, Telemark Hospital)

Methodology and interests:

  • Epidemiology
  • Clinical research and clinical trials in MS
  • Environmental factors associated with MS
  • Socioeconomic factors as predictors of health
 

Publications 2021

Eid K, Torkildsen OF, Aarseth J, Flemmen HO, Holmoy T, Lorentzen AR, Myhr KM, Riise T, Simonsen C, Torkildsen CF, Wergeland S, Willumsen JS, Oksendal N, Gilhus NE, Bjork MH (2021)
Perinatal Depression and Anxiety in Women With Multiple Sclerosis A Population-Based Cohort Study
Neurology, 96 (23), E2789-E2800
DOI 10.1212/WNL.0000000000012062

Flemmen HO, Simonsen CS, Broch L, Brunborg C, Berg-Hansen P, Moen SM, Kersten H, Celius EG (2021)
Maternal education has significant influence on progression in multiple sclerosis
Mult. Scler. Relat. Disord., 53, 103052
DOI 10.1016/j.msard.2021.103052

Simonsen CS, Flemmen HO, Broch L, Brunborg C, Berg-Hansen P, Moen SM, Celius EG (2021)
The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression
J. Neurol., 268 (4), 1330-1341
DOI 10.1007/s00415-020-10279-7

Simonsen CS, Flemmen HO, Broch L, Brunborg C, Berg-Hansen P, Moen SM, Celius EG (2021)
Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry
Front. Neurol., 12, 693017
DOI 10.3389/fneur.2021.693017

Simonsen CS, Flemmen HO, Broch L, Brunborg C, Berg-Hansen P, Moen SM, Celius EG (2021)
No significant differences in absenteeism or academic achievements in a Norwegian multiple sclerosis case control study
Mult. Scler. Relat. Disord., 54, 103141
DOI 10.1016/j.msard.2021.103141

Publications 2020

Eikeland R, Ljostad U, Helgeland G, Sand G, Flemmen HO, Bo MH, Nordaa L, Owe JF, Mygland A, Lorentzen AR (2020)
Patient-reported outcome after treatment for definite Lyme neuroborreliosis
Brain Behav., 10 (4), e01595
DOI 10.1002/brb3.1595

Flemmen HO, Simonsen CS, Berg-Hansen P, Moen SM, Kersten H, Heldal K, Celius EG (2020)
Prevalence of multiple sclerosis in rural and urban districts in Telemark county, Norway
Mult. Scler. Relat. Disord., 45, 102352
DOI 10.1016/j.msard.2020.102352

Simonsen CS, Flemmen HO, Lauritzen T, Berg-Hansen P, Moen SM, Celius EG (2020)
The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis
Mult. Scler. J. Exp. Transl. Clin., 6 (1), 2055217319901291
DOI 10.1177/2055217319901291

Publications 2017

Lorentzen AR, Forselv KJN, Helgeland G, Salvesen RE, Sand G, Flemmen HO, Bo MH, Nordaa L, Roos AK, Jim MW, Owe JF, Nyquist KB, Schuler S, Eikeland R, Mygland A, Ljostad U (2017)
Lyme neuroborreliosis: do we treat according to guidelines?
J. Neurol., 264 (7), 1506-1510
DOI 10.1007/s00415-017-8559-z

Scroll to top